利润表（九洲药业）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 3,965,261,223.17 | 2,764,279,820.31 | 1,475,743,576.44 | 5,523,418,175.43 | 4,576,609,415.43 | 3,254,642,522.09 | 1,751,242,194.31 |
| 营业收入(元) | 3,965,261,223.17 | 2,764,279,820.31 | 1,475,743,576.44 | 5,523,418,175.43 | 4,576,609,415.43 | 3,254,642,522.09 | 1,751,242,194.31 |
| 二、营业总成本(元) | 3,190,787,304.91 | 2,176,923,770.53 | 1,168,180,070.26 | 4,275,834,833.86 | 3,422,488,804.64 | 2,473,324,172.52 | 1,355,118,342.40 |
| 营业成本(元) | 2,587,368,120.12 | 1,790,907,120.13 | 973,336,263.69 | 3,443,493,393.32 | 2,777,615,988.98 | 2,004,766,888.23 | 1,105,105,791.31 |
| 研发费用(元) | 240,137,612.13 | 160,008,049.72 | 64,871,910.84 | 330,827,761.17 | 239,837,436.31 | 167,026,236.56 | 78,769,888.33 |
| 营业税金及附加(元) | 40,089,787.46 | 31,781,297.47 | 20,367,756.91 | 49,204,012.10 | 32,351,336.89 | 21,130,947.23 | 11,979,543.68 |
| 销售费用(元) | 72,344,977.48 | 43,892,002.85 | 20,156,806.67 | 82,017,748.26 | 65,159,308.99 | 44,791,768.38 | 22,908,710.71 |
| 管理费用(元) | 300,560,133.50 | 197,947,419.63 | 108,335,352.12 | 445,926,655.97 | 364,074,011.02 | 267,192,893.44 | 128,470,705.92 |
| 财务费用(元) | -49,713,325.78 | -47,612,119.27 | -18,888,019.97 | -75,634,736.96 | -56,549,277.55 | -31,584,561.32 | 7,883,702.45 |
| 其中：利息费用(元) | 16,307,011.53 | 14,233,916.01 | 8,070,432.96 | 21,733,602.90 | 18,108,655.68 | 10,848,649.73 | 4,642,479.18 |
| 其中：利息收入(元) | 72,828,114.90 | 57,715,485.93 | 26,450,493.61 | 91,824,261.69 | 64,205,991.87 | 29,860,706.30 | 6,043,485.28 |
| 三、其他经营收益 | |||||||
| 加：公允价值变动收益(元) | - | - | - | - | 5,168,114.86 | 576,410.55 | 7,125,347.46 |
| 加：投资收益(元) | -4,629,630.62 | -5,328,237.59 | -2,341,966.21 | -19,363,697.54 | -22,720,384.66 | -15,436,435.93 | -6,516,139.73 |
| 其中：对联营企业和合营企业的投资收益(元) | -8,288,772.93 | -5,328,237.59 | -2,341,966.21 | -7,756,000.25 | -5,120,409.66 | -3,258,065.93 | -1,627,894.73 |
| 资产处置收益(元) | -2,099,975.26 | -2,811,070.01 | -2,172,342.18 | -2,543,160.71 | -1,520,700.72 | -454,152.75 | -123,259.64 |
| 资产减值损失(元) | -38,630,224.50 | -26,268,486.77 | -108,206.84 | -78,203,593.39 | -52,664,633.45 | -52,325,556.38 | -37,005,839.02 |
| 信用减值损失(元) | -12,933,546.38 | -21,984,102.86 | -33,969,218.86 | -20,173,755.07 | -24,939,500.36 | -17,238,689.56 | -16,342,638.65 |
| 其他收益(元) | 30,919,535.52 | 23,710,282.30 | 11,114,786.63 | 48,472,250.12 | 28,407,949.20 | 18,509,235.00 | 6,191,630.92 |
| 四、营业利润(元) | 747,100,077.02 | 554,674,434.85 | 280,086,558.72 | 1,175,771,384.98 | 1,085,851,455.66 | 714,949,160.50 | 349,452,953.25 |
| 加：营业外收入(元) | 651,393.57 | 580,391.26 | 16,616.01 | 8,023,633.72 | 6,703,053.94 | 6,370,783.33 | 297,631.27 |
| 减：营业外支出(元) | 1,041,692.65 | 384,163.07 | 61,133.27 | 3,152,981.13 | 4,537,541.59 | 3,587,378.31 | 272,124.05 |
| 五、利润总额(元) | 746,709,777.94 | 554,870,663.04 | 280,042,041.46 | 1,180,642,037.57 | 1,088,016,968.01 | 717,732,565.52 | 349,478,460.47 |
| 减：所得税费用(元) | 113,857,286.13 | 79,257,105.79 | 43,869,153.92 | 149,270,261.88 | 123,580,385.24 | 96,411,773.12 | 70,021,360.04 |
| 六、净利润(元) | 632,852,491.81 | 475,613,557.25 | 236,172,887.54 | 1,031,371,775.69 | 964,436,582.77 | 621,320,792.40 | 279,457,100.43 |
| (一)按经营持续性分类 | |||||||
| 持续经营净利润(元) | 632,852,491.81 | 475,613,557.25 | 236,172,887.54 | 1,031,371,775.69 | 964,436,582.77 | 621,320,792.40 | 279,457,100.43 |
| (二)按所有权归属分类 | |||||||
| 归属于母公司股东的净利润(元) | 630,876,705.82 | 474,988,640.43 | 236,758,875.39 | 1,033,255,687.14 | 966,770,643.95 | 621,727,529.68 | 280,694,039.23 |
| 少数股东损益(元) | 1,975,785.99 | 624,916.82 | -585,987.85 | -1,883,911.45 | -2,334,061.18 | -406,737.28 | -1,236,938.80 |
| 扣除非经常性损益后的净利润(元) | 618,164,107.97 | 467,847,745.80 | 233,891,236.38 | 1,024,292,645.51 | 951,615,151.08 | 612,711,252.47 | 274,128,312.35 |
| 七、每股收益 | |||||||
| 一、基本每股收益(元) | 0.70 | 0.53 | 0.26 | 1.16 | 1.09 | 0.70 | 0.32 |
| 二、稀释每股收益(元) | 0.70 | 0.53 | 0.26 | 1.16 | 1.09 | 0.70 | 0.32 |
| 八、其他综合收益(元) | -3,871,050.78 | 1,710,782.56 | 2,362,921.59 | 2,052,331.71 | 5,785,327.02 | 6,140,465.48 | 1,417,470.14 |
| 归属于母公司股东的其他综合收益(元) | -3,871,050.78 | 1,710,782.56 | 2,362,921.59 | 2,052,331.71 | 5,785,327.02 | 6,140,465.48 | 1,417,470.14 |
| 九、综合收益总额(元) | 628,981,441.03 | 477,324,339.81 | 238,535,809.13 | 1,033,424,107.40 | 970,221,909.79 | 627,461,257.88 | 280,874,570.57 |
| 归属于母公司所有者的综合收益总额(元) | 627,005,655.04 | 476,699,422.99 | 239,121,796.98 | 1,035,308,018.85 | 972,555,970.97 | 627,867,995.16 | 282,111,509.37 |
| 归属于少数股东的综合收益总额(元) | 1,975,785.99 | 624,916.82 | -585,987.85 | -1,883,911.45 | -2,334,061.18 | -406,737.28 | -1,236,938.80 |
| 公告日期 | 2024-10-25 | 2024-08-27 | 2024-04-25 | 2024-04-09 | 2023-10-28 | 2023-08-15 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | ||||||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 其中：利息收入(元) |
| 三、其他经营收益 |
| 加：公允价值变动收益(元) |
| 加：投资收益(元) |
| 其中：对联营企业和合营企业的投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 八、其他综合收益(元) |
| 归属于母公司股东的其他综合收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 44 of 44 entries